Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing’ vascular segments

Penumbra’s stock was up about 12% after the deal was announced Thursday morning.
#Boston #Scientific #buying #Penumbra #billion #gaining #entry #fastgrowing #vascular #segments